3 assets in Alpha-Mannosidosis

Therapeutic assets addressing Alpha-Mannosidosis, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Busulfanum Alpha-Mannosidosis	Masonic Cancer Center, University of Minnesota	P2	B (61)
Cald Hr-D Alpha-Mannosidosis	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
Duoc-01 Alpha-Mannosidosis	Joanne Kurtzberg, MD	P1	CC (43)